Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
End Stage Liver DIsease: early-phase trial registry
11 of 17 indexed End Stage Liver DIsease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 11 currently recruiting · #1,004 of 28,707 conditions by registered trial count
End Stage Liver DIsease: 17 US clinical trials tracked, 11 recruiting.
End Stage Liver DIsease is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is University of Pennsylvania, running 2 of these trials.
Enrollment posture brief
Registry condition end-stage-liver-disease
OPEN 11 | RECR 65% | LATE 1 | EARLY 4 | RANK #1004 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Autism Spectrum Disorder (ASD) (65% recruiting · 17 trials)
End Stage Liver DIsease lists 11 open slots (65% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for End Stage Liver DIsease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
End Stage Liver DIsease is recruiting above its size-band peers.
11 of 17 indexed trials (64.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of End Stage Liver DIsease trials is spread across many organizations.
University of Pennsylvania accounts for 2 of 17 trials (11.8%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical End Stage Liver DIsease enrolment sits around 100 participants.
Median target enrolment is 100 among the 17 trials that report a genuine target (sentinel values excluded). 7 of those (41.2%) plan for fewer than 100 participants.
-
End Stage Liver DIsease research is mostly interventional.
14 interventional and 3 observational studies make up this index (82.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Functional Assessment in Liver Transplantation
University of California, San Francisco
NCT03228290
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
Johns Hopkins University
NCT03803423
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
University of Pennsylvania
NCT05260268
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Massachusetts General Hospital
NCT05998330
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
University of Pennsylvania
NCT06136221
Disparities Among Liver Transplant Patients
Mayo Clinic
NCT05981196
Adverse Outcomes and Mortality in Liver Transplant
Mayo Clinic
NCT05477277
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Massachusetts General Hospital
NCT05205954
Immune Tolerance Induction After Liver Transplantation
University of California, Los Angeles
NCT07269041
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
LyGenesis
NCT04496479
A Study of SIPLIZUMAB in AILD and LT Patients
Elizabeth C. Verna
NCT06455280
Tocotrienol Against the Progression of End Stage Liver Disease
Chandan Sen
NCT02581085
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Baylor Research Institute
NCT00163657
Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation
Bridge to Life
NCT05045794
Psychosocial Risks in Liver Transplant Recipients
Icahn School of Medicine at Mount Sinai
NCT02826460
Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease
Vanderbilt University Medical Center
NCT06400498
End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
University of Cincinnati
NCT00374582
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on End Stage Liver DIsease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on End Stage Liver DIsease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this End Stage Liver DIsease page
17 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 End Stage Liver DIsease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Pennsylvania sponsors the most End Stage Liver DIsease trials on record, review their full trial history before evaluating a specific study. See University of Pennsylvania's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This End Stage Liver DIsease condition card totals 17 registered trials; most-linked intervention bodystat quadscan 400; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.